Your morning cup of coffee is doing more than waking you up. It is feeding a specific community of bacteria in your gut, and those microbes appear to produce compounds linked to sharper thinking and lower stress. What makes this finding unusual is that decaf coffee does it too, suggesting caffeine is not the ingredient that matters most.
That conclusion comes from a registered human trial, documented on ClinicalTrials.gov under identifier NCT05927103, with results reported in Nature Communications in early 2026. Researchers recruited healthy moderate coffee drinkers and non-drinkers, then tracked what happened when habitual drinkers stopped coffee entirely and later reintroduced either caffeinated or decaffeinated versions. Using shotgun metagenomics, metabolomics, and behavioral questionnaires, the team found that both caffeinated and decaf coffee shifted gut microbiome composition in similar ways. Reintroduction restored bacterial profiles that had been disrupted during withdrawal, and the changes tracked alongside improvements in self-reported mood and stress.
The polyphenol connection
If caffeine is not driving the microbiome shift, what is? The leading candidates are chlorogenic acids, a family of polyphenol compounds that survive the decaffeination process largely intact. Both regular and decaf coffee deliver substantial amounts of these molecules to the lower gut, where resident bacteria break them down into smaller metabolites, including dihydrocaffeic acid and other phenolic compounds. Blood samples from participants in the trial confirmed that these metabolites rose after coffee consumption regardless of caffeine content, and their timing pointed to gut bacterial production rather than direct absorption from the stomach.
“Coffee turned out to be one of the strongest and most reproducible dietary signals we have ever seen in microbiome research,” the authors of a separate large-scale study published in Nature Microbiology in 2024 wrote in their paper. Analyzing data across multiple independent populations, that team identified Lawsonibacter asaccharolyticus as a gut bacterium whose abundance rose consistently among coffee drinkers. The association held for both caffeinated and decaffeinated intake in tested subsets.
Tim Spector, a genetic epidemiologist at King’s College London who studies diet-microbiome interactions but was not involved in either study, has noted in public commentary that the coffee findings stand out because so few dietary exposures produce signals this consistent across populations. A Nature news feature covering these findings similarly highlighted the coffee-microbiome connection as a standout result in a field where most diet-related associations are weak or inconsistent.
Where the science gets less certain
The evidence that coffee reshapes gut bacteria is strong. The evidence that those bacterial changes actually improve how people feel is considerably weaker.
The Nature Communications trial documented that withdrawal disrupted microbial profiles and that reintroduction restored them alongside better self-reported mood and lower perceived stress. But self-reported questionnaires are not the same as clinical measures like cortisol levels tracked over months, and the study design, while more rigorous than a simple observational survey, cannot definitively prove that the bacterial shifts caused the psychological improvements. Participants knew whether they were drinking coffee or not, which introduces expectation effects that are difficult to control for.
No long-term randomized controlled trial has yet tested whether sustained coffee-driven microbiome changes produce lasting improvements in mood or stress resilience. The existing evidence spans weeks, not years. Whether Lawsonibacter asaccharolyticus and other enriched species actively produce neuroactive metabolites, or simply happen to flourish alongside other beneficial changes, has not been isolated.
Earlier laboratory and animal research has suggested that gut bacteria play a role in breaking down chlorogenic acids into bioactive metabolites, but those mechanistic findings have not been fully confirmed in controlled human studies. The human trial’s plasma data are consistent with gut bacterial processing, yet the precise contribution of specific microbial species to chlorogenic acid metabolism in living people remains an open question.
Individual variation complicates things further. Gut microbiome composition differs widely based on genetics, diet, medications, and geography. Someone whose baseline microbiome lacks the bacteria capable of transforming chlorogenic acids may not experience the same metabolite surge and may not see the same cognitive or emotional effects. The studies tested healthy adults in specific populations, leaving open questions about how the findings apply to people with gastrointestinal conditions, those on antibiotics, or communities outside the studied cohorts.
There are also practical variables the trials did not focus on: whether dark roast versus light roast matters, whether espresso delivers the same polyphenol load as drip coffee, and whether adding milk or sugar alters the gut bacterial response. These are the kinds of questions readers will naturally ask, and the honest answer, as of June 2026, is that the data do not yet exist to answer them with confidence.
Three tiers of confidence
It helps to think about this research in layers.
Well established: Coffee changes gut bacteria, and both caffeinated and decaf versions do so. This is supported by direct microbiome sequencing before and after changes in coffee intake, confirmed across multiple independent cohorts.
Probable but not proven: Those bacterial changes produce metabolites that enter the bloodstream and could influence brain function. Blood measurements show the right compounds appearing at the right times, but the full pathway from gut metabolite to neural effect has not been traced in humans.
Plausible but early: Those metabolites meaningfully improve mood and reduce stress over time. This is where most of the public excitement sits, and it is where the evidence is thinnest. Ongoing and future trials will need to separate real effects from placebo responses and short-term fluctuations.
What this means for your coffee habit
The practical takeaway is genuinely useful, even if it is modest. The polyphenol content in both types of coffee appears to be the main driver of the microbiome changes, not the caffeine. That means people who are sensitive to caffeine, prone to insomnia, or managing conditions like high blood pressure can reasonably choose decaf and still expect many of the same gut-level effects observed in the studies.
But coffee is not a therapy for anxiety, depression, or chronic stress. The current data do not justify treating it as a substitute for evidence-based mental health care, and they do not show that drinking more coffee will produce proportionally greater benefits. Coffee can also cause or worsen heartburn, palpitations, and sleep disruption in some people, all of which can undermine mood and stress resilience on their own. The participants in these studies were moderate drinkers, generally consuming three to five cups per day, not heavy consumers.
Researchers are now working to identify the specific bacterial strains and metabolites most strongly linked to cognitive and emotional outcomes, and to test whether polyphenol-rich supplements or microbiome-directed therapies could reproduce the effects without requiring coffee at all. Until those results arrive, the most grounded reading of the evidence is that moderate coffee intake, caffeinated or decaf, fits well within a gut-friendly dietary pattern. It is one credible piece of a much larger puzzle connecting what you eat, what lives in your gut, and how your brain responds to stress.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
